TSHA - Taysha Gene Therapies, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - TSHA (1806310)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
15 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-11-17
TSHAManning Paul B10%P - Purchase$1.63+100,00023,517,7780%+$163,000
2023-08-24
TSHAAlam KamranCFOS - Sale$2.33-33,000258,042-11%-$76,890
2023-08-16
TSHAManning Paul B10%P - Purchase$0.90+16,466,66723,417,778+237%+$14,820,000
2023-08-16
TSHAStalfort John A IIIDirP - Purchase$0.90+777,7781,933,671+67%+$700,000
2023-08-16
TSHANolan Sean P.CEOP - Purchase$0.90+444,4441,536,715+41%+$400,000
2023-08-16
TSHADonenberg Phillip B.DirP - Purchase$0.90+111,111114,111>999%+$100,000
M
2023-07-12
TSHASession R.A. II10%S - Sale$0.71-85,8729,153,927-1%-$60,771
M
2023-06-22
TSHASession R.A. II10%S - Sale$0.70-28,6089,239,7990%-$20,119
M
2023-06-20
TSHASession R.A. II10%S - Sale$0.71-434,6159,268,407-4%-$307,844
2023-05-16
TSHANagendran SukumarPres, Head of R, DP - Purchase$0.68+5,00034,226+17%+$3,400
2022-10-31
TSHAManning Paul BDir, 10%P - Purchase$2.00+1,500,0006,951,111+28%+$3,000,000
2022-08-23
TSHAAlam KamranCFOS - Sale$3.47-3,325266,121-1%-$11,538
M
2022-08-18
TSHAAlam KamranCFOS - Sale$3.70-28,675269,446-10%-$105,999
M
2022-07-05
TSHAPrasad SuyashCMO, Head of R, DS - Sale$3.70-12,861530,589-2%-$47,650
M
2022-06-29
TSHAPrasad SuyashCMO, Head of R, DS - Sale$3.65-50,139543,450-8%-$183,081

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top